TIDMFFWD
RNS Number : 0480C
FastForward Innovations Limited
16 January 2018
16(th) January 2018
FastForward Innovations Limited
("FastForward")
Investee Company Update: Nuuvera and Globalive Technologies
partners to bring blockchain to the global medical cannabis
industry in groundbreaking collaboration
FastForward is pleased to note the announcement by investee
company Nuuvera Corp. ("Nuuvera" (TSXV: NUU)), a public company
formed to capitalize on the global trend towards the legalization
of medical cannabis, in which FastForward has a holding of 3.75%.
The full announcement is set out below. GTP is a Canadian company
specializing in improving existing businesses and economies by
utilizing disruptive technologies, specifically artificial
intelligence, internet of things, and blockchain technology.
'Nuuvera Inc. ("Nuuvera") (TSXV: NUU) is proud to announce it is
entering into a joint partnership with Globalive Technology
Partners (GTP) to bring blockchain technology to the global
cannabis market.
Following the joint development of the blockchain technology,
both Nuuvera and GTP will license the software around the globe to
help increase the safety and security of records as well as help
supply chain management globally.
The first of its kind partnership will see Nuuvera and GTP
developing proprietary blockchain technology that will help
validate the integrity and grade of cannabis products, from source
to consumer.
"We're extremely excited to partner with Anthony Lacavera and
GTP on this disruptive global cannabis technology. In applying
blockchain technology to this emerging industry, we will continue
to shape the global cannabis market, and set an incredibly high bar
for safety and consistency that will benefit patients everywhere,"
said Nuuvera CEO, Lorne Abony.
"Nuuvera's mission is to lead the emerging cannabis industry by
developing safe, consistent, and effective products for patients.
We are already leveraging the capabilities of our global network
with an aim of becoming the most innovative cannabis company in the
world. Through this partnership with GTP, we can use blockchain
technology to ensure the integrity and grade of our products - from
source to retail. This demonstrates our deep commitment to leading
the global cannabis industry in a positive and meaningful way,"
Lorne continued.
GTP - who announced last week they will go public in 2018 -- is
forming partnerships with a very select group of leading companies
across a variety of sectors who recognize the strategic advantage
of incorporating blockchain into their sectors. GTP have selected
Nuuvera as the sole partner for the emerging and burgeoning global
cannabis market.
Anthony Lacavera, co-founder and CEO of GTP stated, "At GTP we
share Nuuvera's vision to help build an innovative and safe global
cannabis market. We also want to see consumers receive the safest,
highest quality products. That's why we are delighted to choose
Nuuvera as our sole partner to bring machine intelligence and
blockchain technology to the cannabis industry."
For more information on Nuuvera, please visit:
www.nuuvera.com
Lorne Abony, CEO of Nuuvera, said
"We are hugely excited to be pioneering Blockchain technology
into the medical Cannabis industry. With our multinational
agreements we feel that Nuuvera is in prime position to
revolutionise the medical cannabis sector.
"With offices in Toronto, Tel Aviv, Hamburg, and Milan, we are
positioned to serve diversified international markets with medical
grade cannabis products, and through Blockchain technology we feel
we can further legitimise this fast growing global business" said
Abony.'
For more information on Nuuvera, please visit:
www.nuuvera.com
About Nuuvera
Nuuvera is a global medical cannabis company founded on Canadian
principles, and built with the whole world in mind. Nuuvera is
currently working with partners in Germany, Israel and Italy, and
is exploring opportunities in several other countries, to develop
commercial production and global distribution of medical grade
cannabis in legalized markets. Through its subsidiaries, ARA -
Avanti Rx Analytics Inc. and Avalon Pharmaceutical Inc., Nuuvera
holds a Dealer License (GMP) under the Narcotic Control Regulations
and Office of Controlled Substances. Nuuvera is currently in the
final stages of the Health Canada review process to become a
Licensed Producer of medical marijuana under the ACMPR, and has
recently received its "letter to build" approval.
For further information please visit www.fstfwd.co or
contact:
FastForward Innovations Limited info@fstfwd.co
Sue Saunders/ Ian Burns
------------------------------------------------------------
Beaumont Cornish Limited (Nomad) Tel: +44 (0) 207 628 3396
James Biddle / Roland Cornish
------------------------------------------------------------
Optiva Securities Limited (Broker) Tel: +44 (0) 203 411 1881
Ed McDermott
------------------------------------------------------------
CAUTIONARY STATEMENT
The AIM Market of London Stock Exchange plc does not accept
responsibility for the adequacy or accuracy of this release. No
stock exchange, securities commission or other regulatory authority
has approved or disapproved the information contained herein. All
statements, other than statements of historical fact, in this news
release are forward-looking statements that involve various risks
and uncertainties, including, without limitation, statements
regarding potential values, the future plans and objectives of
FastForward Innovations Ltd. There can be no assurance that such
statements will prove to be accurate, achievable or recognizable in
the near term.
Actual results and future events could differ materially from
those anticipated in such statements. These and all subsequent
written and oral forward-looking statements are based on the
estimates and opinions of management on the dates they are made and
are expressly qualified in their entirety by this notice.
FastForward Innovations assumes no obligation to update
forward-looking statements should circumstances or management's
estimates or opinions change.
This announcement contains inside information for the purposes
of Article 7 of EU Regulation 596/2014
This information is provided by RNS
The company news service from the London Stock Exchange
END
UPDUNOVRWOAAAAR
(END) Dow Jones Newswires
January 16, 2018 10:36 ET (15:36 GMT)
Seed Innovations (LSE:SEED)
Historical Stock Chart
From Mar 2024 to Apr 2024
Seed Innovations (LSE:SEED)
Historical Stock Chart
From Apr 2023 to Apr 2024